Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 79,516 |
|
|||||
| News | - | ||||||
| Day High | 0.8195 | Low High |
|||||
| Day Low | 0.7604 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0645 | -7.78% | 0.7642 | 23:00:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.8003 | 0.7604 | 0.8195 | 0.781 | 0.8287 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 395 | 79,516 | US$ 0.7796217 | US$ 61,992 | - | 0.67 - 80.96 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:55:19 | 14 | US$ 0.7642 | USD |
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 421.44k | 533.46k | - | 0 | -17.41M | -32.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptevo Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/10/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/03/2024 | 15:58 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 6/03/2024 | 15:42 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 6/03/2024 | 15:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/08/2024 | 07:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/08/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/07/2024 | 07:56 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 16:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 15:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 3/05/2024 | 15:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 3/05/2024 | 07:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 3/05/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8066 | 0.89 | 0.7604 | 0.8292754 | 99,187 | -0.0424 | -5.26% |
| 1 Month | 0.8224 | 0.89 | 0.702 | 0.7800418 | 155,195 | -0.0582 | -7.08% |
| 3 Months | 5.03 | 5.04 | 0.67 | 1.17 | 905,372 | -4.27 | -84.81% |
| 6 Months | 7.92 | 10.80 | 0.67 | 3.21 | 653,063 | -7.16 | -90.35% |
| 1 Year | 69.96 | 80.96 | 0.67 | 10.21 | 536,789 | -69.20 | -98.91% |
| 3 Years | 1,149.72 | 1,397.44 | 0.67 | 387.23 | 581,226 | -1,148.96 | -99.93% |
| 5 Years | 36.5156 | 2,640.00 | 0.67 | 414.20 | 573,986 | -35.75 | -97.91% |
Aptevo Therapeutics Description
| Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. |
